Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$212K Sell
2,947
-653
-18% -$61.5K 0.02% 438
2026
Q1
$426K Sell
3,600
-1,542
-30% -$191K 0.04% 244
2025
Q4
$647K Sell
5,142
-138
-3% -$18K 0.07% 149
2025
Q3
$773K Sell
5,280
-596
-10% -$90.1K 0.08% 128
2025
Q2
$916K Buy
5,876
+1,787
+44% +$283K 0.1% 122
2025
Q1
$673K Buy
4,089
+1,746
+75% +$290K 0.08% 140
2024
Q4
$382K Buy
2,343
+873
+59% +$156K 0.05% 217
2024
Q3
$287K Buy
1,470
+155
+12% +$28.6K 0.04% 250
2024
Q2
$228K Sell
1,315
-326
-20% -$54.3K 0.03% 268
2024
Q1
$278K Buy
1,641
+380
+30% +$71.2K 0.05% 236
2023
Q4
$249K Buy
+1,261
New +$223K 0.05% 229
2020
Q1
Sell
-3,229
Closed -$427K 197
2019
Q4
$427K Buy
+3,229
New +$401K 0.1% 113

Other funds holding ZTS

LVW Advisors's ZTS Position: Q2 2026 in Review

LVW Advisors reduced its Zoetis (ZTS) stake by 18% in Q2 2026, selling an estimated $61.5K and leaving 2,947 shares worth $212K. The position accounts for 0.02% of the portfolio, ranked #438.

LVW Advisors first reported a position in ZTS in Q4 2019 and has held it in 12 quarters since. The position peaked at $916K in Q2 2025. 590 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • LVW Advisors held 2,947 shares of Zoetis worth $212K as of Q2 2026.
  • LVW Advisors sold 653 Zoetis shares in Q2 2026, an estimated $61.5K.
  • Zoetis made up 0.02% of LVW Advisors's portfolio in Q2 2026, its #438 holding.
  • LVW Advisors first reported a position in Zoetis in Q4 2019 and has held it in 12 quarters since.
  • LVW Advisors's Zoetis position peaked at $916K in Q2 2025.
  • 590 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on LVW Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.